Replies to post #5212 on ALR Technologies SG Ltd (ALRTF)

[10thMountain]

And there's another patented part of this new feature coming out that has not been announced yet according to the company. They will announce the details to the public soon....

[GrandeS]

These are web based platforms. The Health E Connect is great, but needed the Insulin Dose Adjustment to complete it. Now it's all marketable as an enhanced diabetes management platform. When the new devise that is being referred to is added (wish we knew what it is) I assume it will make the diabetes management benefits more complete. There is no similar service platform device on the market. They should dominate once a large partnering pharmaceutical company with diabetes medications or insulin joins up with them.

[why_meil]

I'm well aware of that. This clearance is for the insulin dose adjustment feature to the original device that they applied for last December with the FDA.

In my opinion this addition is what sets ALR's monitoring system apart from the competition's.

And watch this stock stair step higher as they announce details of sponsorship, product launches, SEC compliance, etc...

Lots of upside here in my opinion, with less risks than most stinky pinkies. This FDA clearance is a game changer for ALR.